샘플 요청 목록

 카트 문의
시장보고서
상품코드
1665872

인공 경막 시장 : 성장, 전망, 경쟁 분석(2025-2033년)

Dura Substitute Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 176 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인공 경막 시장은 뇌와 척수를 덮고 있는 외막인 경막을 복구하거나 대체하기 위해 신경외과에서 사용되는 제품과 재료로 구성됩니다. 인공 경막은 일반적으로 종양 절제, 외상 복구, 경막을 열어야 하는 모든 개입과 같은 신경 외과 수술 후에 사용됩니다. 이 인공 경막은 뇌척수액 누출을 방지하고 내구성 있는 장벽을 제공하여 중추 신경계를 보호하도록 설계되었습니다. 여기에는 생물학적 이식편, 합성 물질, 그리고 생체 적합성과 감염 및 염증의 위험 감소를 제공하는 복합 제품 등이 있습니다. 인공 경막 시장 규모는 연평균 성장률(CAGR) 5.7%로 성장할 것으로 예상됩니다. 이러한 성장은 신경외과 수술의 지속적인 기술 발전, 신흥국의 의료비 지출 증가, 복잡한 신경외과 수술에 사용할 수 있는 옵션에 대한 인식이 높아짐에 따른 것으로 분석됩니다.

뇌종양, 외상, 신경 퇴행성 질환과 같은 신경 질환의 유병률이 증가함에 따라 전 세계적으로 신경 외과 수술 건수가 증가하는 것이 인공 경막 시장의 주요 촉진요인으로 작용하고 있습니다. 인구가 고령화되고 의료 영상이 개선됨에 따라 더 많은 신경학적 문제가 진단되고 경막 수복이 필요한 개입이 필요하게 됩니다. 또한, 신경외과 수술의 발전으로 치료 가능한 질환의 범위가 넓어지면서 환자의 안전과 최적의 수술 결과를 보장하는 신뢰할 수 있는 인공 경막에 대한 수요도 증가하고 있습니다. 이러한 재료는 수술 후 심각한 합병증을 유발할 수 있는 뇌척수액 누출을 방지하는 데 필수적입니다. 고품질 인공 경막을 사용할 수 있게 되면 신경외과 의사는 복잡한 수술의 위험을 줄이면서 환자의 회복시간과 수술 성공률을 높일 수 있습니다.

인공 경막 시장에는 생체 재료의 기술 혁신으로 인한 큰 기회가 있습니다. 천연 경막을 모방한 합성 및 생물학적 재료의 개발은 인체 조직과의 통합성을 향상시키고, 치유 과정을 강화하며, 신체 거부반응을 감소시킬 수 있습니다. 인공 경막에 항균 특성을 통합하고 기계적 강도를 강화하는 등의 혁신은 수술 후 감염을 더욱 최소화하고 외과적 수복물의 내구성을 보장할 수 있습니다. 이러한 발전은 환자의 예후를 개선할 뿐만 아니라 신경외과에서 인공 경막의 잠재적 용도를 확장하고, 제품의 기능이 계속 발전함에 따라 시장 성장의 새로운 길을 열어줄 것입니다.

세계의 인공 경막 시장에 대해 조사했으며, 시장 개요와 함께 재료별/용도별/최종사용자별/지역별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서문

제2장 주요 요약

제3장 인공 경막 시장 : 경쟁 분석

  • 주요 벤더의 시장 포지셔닝
  • 벤더가 채택한 전략
  • 주요 업계 전략

제4장 인공 경막 시장 : 매크로 분석과 시장 역학

  • 서론
  • 세계의 인공 경막 시장 가치, 2023년-2033년
  • 시장 역학
  • 성장 촉진요인과 억제요인의 영향 분석
  • See-Saw 분석
  • Porter's Five Forces 모델
  • PESTEL 분석

제5장 인공 경막 시장 : 2023년-2033년

  • 시장 개요
  • 성장과 매출 분석 : 2024년 vs. 2033년
  • 시장 세분화

제6장 인공 경막 시장 : 재료별, 2023년-2033년

  • 시장 개요
  • 성장과 매출 분석 : 2024년 vs. 2033년
  • 시장 세분화
    • 생물학적 이식
    • 합성 이식편

제7장 인공 경막 시장 : 용도별, 2023년-2033년

  • 시장 개요
  • 성장과 매출 분석 : 2024년 vs. 2033년
  • 시장 세분화
    • 뇌신경외과
    • 척추수술

제8장 인공 경막 시장별 : 최종사용자별, 2023년-2033년

  • 시장 개요
  • 성장과 매출 분석 : 2024년 vs. 2033년
  • 시장 세분화
    • 병원
    • 외래수술센터(ASC)
    • 기타

제9장 북미의 인공 경막 시장 : 2023년-2033년

제10장 영국 및 EU의 인공 경막 시장 : 2023년-2033년

제11장 아시아태평양의 인공 경막 시장 : 2023년-2033년

제12장 라틴아메리카의 인공 경막 시장 : 2023년-2033년

제13장 중동 및 아프리카의 인공 경막 시장 : 2023년-2033년

제14장 기업 개요

  • Cook Medical LLC
  • B. Braun Melsungen AG
  • Integra LifeSciences
  • Cousin Surgery
  • WL Gore &Associates Inc.
  • Biosynth Lifesciences
  • Acera Surgical Inc.
  • Medprin
  • Medtronic
  • Stryker
  • DePuy Synthes
  • Gunze Limited
  • Baxter
  • Bennett Health Inc.
  • RTI Surgical
  • Natus Medical Incorporated
  • 기타 저명한 선수
LSH 25.03.12

The dura substitute market comprises products and materials used in neurosurgery to repair or replace the dura mater, the outer membrane covering the brain and spinal cord. Dura substitutes are typically employed following neurosurgical procedures such as tumor resection, trauma repair, or any intervention that necessitates the opening of the dura mater. These substitutes are designed to prevent cerebrospinal fluid leaks and protect the central nervous system by providing a durable barrier. They include a range of biologic grafts, synthetic materials, and combination products that offer biocompatibility and reduced risk of infection and inflammation. The dura substitute market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.7%. This growth is indicative of ongoing technological advancements in neurosurgery, increasing healthcare expenditures in emerging economies, and a growing awareness of the options available for complex neurosurgical procedures.

Increasing Neurosurgical Procedures

A primary driver of the dura substitute market is the increasing number of neurosurgical procedures worldwide, attributed to the rising prevalence of neurological disorders, such as brain tumors, trauma, and neurodegenerative diseases. As populations age and medical imaging improves, more neurological issues are diagnosed, necessitating interventions that may require dural repair. Advances in neurosurgery have also expanded the range of treatable conditions, thus increasing the demand for reliable dura substitutes that ensure patient safety and optimal surgical outcomes. These materials are essential in preventing cerebrospinal fluid leaks, which can lead to serious complications post-surgery. The availability of high-quality dura substitutes supports the ability of neurosurgeons to perform complex surgeries with reduced risk, enhancing patient recovery times and surgical success rates.

Technological Innovations in Biomaterials

The dura substitute market is presented with substantial opportunities through technological innovations in biomaterials. Development in synthetic and biologic materials that mimic the natural dura mater offers improved integration with human tissue, enhancing healing processes and reducing the body's rejection rates. Innovations such as the incorporation of antibacterial properties and enhanced mechanical strength in dura substitutes can further minimize postoperative infections and ensure the durability of surgical repairs. These advancements not only improve patient outcomes but also expand the potential applications of dura substitutes in neurosurgery, opening new avenues for market growth as the capabilities of these products continue to evolve.

Cost and Accessibility Issues

However, the market faces significant restraints due to the high costs associated with advanced dura substitutes and accessibility issues in low-income countries. The development and production of cutting-edge biocompatible materials often involve substantial investment, which translates into higher costs for end-users. In regions with limited healthcare funding or inadequate insurance coverage, the availability of advanced dura substitutes can be restricted, limiting market penetration. These financial barriers prevent a substantial segment of the global population from accessing the latest innovations in neurosurgical care, posing a challenge to market expansion and the equitable distribution of healthcare solutions.

Regulatory and Clinical Adoption Challenges

One of the main challenges in the dura substitute market is navigating the stringent regulatory landscape and achieving widespread clinical adoption. New dura substitutes must undergo rigorous testing and approval processes to demonstrate safety and efficacy before they can enter the market. This regulatory scrutiny is necessary to ensure patient safety but can delay product launches and increase development costs. Additionally, gaining acceptance from neurosurgeons, who must trust the reliability and benefit of new materials over traditional methods or existing products, requires substantial clinical evidence and often, educational efforts by manufacturers. This hurdle is compounded by the need to continuously innovate while ensuring that new products can be seamlessly integrated into existing surgical workflows, making the widespread adoption of new dura substitutes a complex and ongoing challenge.

Market Segmentation by Material

In the dura substitute market, products are segmented into biological grafts and synthetic grafts. Biological grafts currently generate the highest revenue within this segment, largely due to their superior biocompatibility and reduced immunogenicity, which are critical in neurosurgical applications to minimize the risk of rejection and complications. These grafts, derived from human or animal tissues, are extensively used as they closely mimic the natural dura mater, promoting better integration and healing. However, synthetic grafts are expected to witness the highest Compound Annual Growth Rate (CAGR) over the forecast period. The growth in synthetic grafts can be attributed to continuous improvements in material science that enhance their functionality and safety. Innovations such as the incorporation of antimicrobial properties and increased mechanical strength make synthetic grafts increasingly attractive. These features, combined with the lower risk of disease transmission compared to biological options and consistency in quality, drive their adoption in both neurosurgery and spinal surgery applications.

Market Segmentation by Application

The dura substitute market is also segmented by application, specifically into neurosurgery and spinal surgery. Neurosurgery accounts for the highest revenue in this market due to the critical nature of surgical interventions on the brain and spinal cord where the dura mater is most frequently manipulated. The precision required in neurosurgery and the high risk of complications such as cerebrospinal fluid leaks make effective dura substitutes essential for successful outcomes. Meanwhile, spinal surgery is projected to experience the highest CAGR from 2025 to 2033. This expected growth is driven by the increasing prevalence of spinal conditions that require surgical intervention, such as herniated discs and spinal tumors, coupled with advancements in spinal surgical techniques. As more complex and minimally invasive spinal procedures are developed, the need for reliable dura substitutes that can conform to different surgical approaches and ensure patient safety is anticipated to rise significantly.

Geographic Segmentation

In 2024, the dura substitute market was predominantly led by North America, which accounted for the highest revenue percentage. This dominance is attributed to advanced healthcare infrastructure, a high prevalence of neurological disorders, and significant investments in research and development within the region. Moreover, the presence of key market players and a robust regulatory framework supporting rapid product innovation contributed to this leading position. However, the Asia-Pacific region is expected to witness the highest Compound Annual Growth Rate (CAGR) from 2025 to 2033. This growth is driven by increasing healthcare expenditure, rising awareness of advanced surgical procedures, and improvements in healthcare infrastructure in populous countries such as China and India. Additionally, the growing prevalence of diseases requiring neurosurgical and spinal surgeries will further fuel the demand for dura substitutes in this region.

Competitive Trends and Top Players

The competitive landscape of the dura substitute market in 2024 featured intense activity from key players such as Cook Medical LLC, B. Braun Melsungen AG, Integra LifeSciences, Cousin Surgery, W. L. Gore & Associates, Inc., Biosynth Lifesciences, Acera Surgical, Inc., Medprin, Medtronic, Stryker, DePuy Synthes, Gunze Limited, Baxter, Bennett Health, Inc., RTI Surgical, and Natus Medical Incorporated. These companies focused extensively on innovation and strategic expansions to strengthen their market positions. Significant efforts were made in developing advanced materials that offer better biocompatibility, enhanced durability, and improved patient outcomes. For instance, companies like Medtronic and Stryker invested heavily in R&D to introduce more refined synthetic and biologic grafts that mimic natural dura mater more closely. From 2025 to 2033, these players are expected to continue their focus on technological advancements and expand their global footprints through strategic alliances, mergers, and acquisitions. Market leaders will likely intensify efforts to penetrate emerging markets, where there is a growing demand for advanced medical treatments. Additionally, increasing regulatory support for rapid product approvals will also help companies in launching innovative solutions more efficiently. The adoption of aggressive marketing strategies and collaborations with healthcare providers will be crucial in enhancing product visibility and adoption.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Dura Substitute market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Dura Substitute market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Material
  • Biological Grafts
  • Autografts
  • Allografts
  • Xenogrfts
  • Decellularized Pericardium
  • Small Intestine Submucosa
  • Collagen
  • Synthetic Grafts
  • Polytetrafluoroethylene (PTFE)
  • Others
  • Application
  • Neurosurgery
  • Spinal Surgery
  • End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Dura Substitute market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Dura Substitute market?
  • Which is the largest regional market for Dura Substitute market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Dura Substitute market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Dura Substitute market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Dura Substitute Market
  • 2.2. Global Dura Substitute Market, By , 2024 (US$ Million)
  • 2.3. Global Dura Substitute Market, By Material, 2024 (US$ Million)
  • 2.4. Global Dura Substitute Market, By Application, 2024 (US$ Million)
  • 2.5. Global Dura Substitute Market, By End-user, 2024 (US$ Million)
  • 2.6. Global Dura Substitute Market, By Geography, 2024 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2024

3. Dura Substitute Market: Competitive Analysis

  • 3.1. Market Positioning of Key Dura Substitute Market Vendors
  • 3.2. Strategies Adopted by Dura Substitute Market Vendors
  • 3.3. Key Industry Strategies

4. Dura Substitute Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Dura Substitute Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Dura Substitute Market: By , 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation

6. Dura Substitute Market: By Material, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Biological Grafts
      • 6.3.1.1. Autografts
      • 6.3.1.2. Allografts
      • 6.3.1.3. Xenogrfts
        • 6.3.1.3.1. Decellularized Pericardium
        • 6.3.1.3.2. Small Intestine Submucosa
        • 6.3.1.3.3. Collagen
    • 6.3.2. Synthetic Grafts
      • 6.3.2.1. Polytetrafluoroethylene (PTFE)
      • 6.3.2.2. Others

7. Dura Substitute Market: By Application, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 7.3. Market Segmentation
    • 7.3.1. Neurosurgery
    • 7.3.2. Spinal Surgery

8. Dura Substitute Market: By End-user, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 8.3. Market Segmentation
    • 8.3.1. Hospitals
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Others

9. North America Dura Substitute Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Dura Substitute Market: By , 2023-2033, USD (Million)
  • 9.3. Dura Substitute Market: By Material, 2023-2033, USD (Million)
  • 9.4. Dura Substitute Market: By Application, 2023-2033, USD (Million)
  • 9.5. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
  • 9.6.Dura Substitute Market: By Region, 2023-2033, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 9.6.1.1.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 9.6.1.1.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 9.6.1.1.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 9.6.1.2.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 9.6.1.2.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 9.6.1.2.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 9.6.1.3.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 9.6.1.3.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 9.6.1.3.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)

10. UK and European Union Dura Substitute Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Dura Substitute Market: By , 2023-2033, USD (Million)
  • 10.3. Dura Substitute Market: By Material, 2023-2033, USD (Million)
  • 10.4. Dura Substitute Market: By Application, 2023-2033, USD (Million)
  • 10.5. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
  • 10.6.Dura Substitute Market: By Region, 2023-2033, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 10.6.1.1.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 10.6.1.1.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 10.6.1.1.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 10.6.1.2.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 10.6.1.2.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 10.6.1.2.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 10.6.1.3.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 10.6.1.3.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 10.6.1.3.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 10.6.1.4.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 10.6.1.4.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 10.6.1.4.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 10.6.1.5.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 10.6.1.5.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 10.6.1.5.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 10.6.1.6.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 10.6.1.6.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 10.6.1.6.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)

11. Asia Pacific Dura Substitute Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Dura Substitute Market: By , 2023-2033, USD (Million)
  • 11.3. Dura Substitute Market: By Material, 2023-2033, USD (Million)
  • 11.4. Dura Substitute Market: By Application, 2023-2033, USD (Million)
  • 11.5. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
  • 11.6.Dura Substitute Market: By Region, 2023-2033, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 11.6.1.1.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 11.6.1.1.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 11.6.1.1.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 11.6.1.2.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 11.6.1.2.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 11.6.1.2.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 11.6.1.3.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 11.6.1.3.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 11.6.1.3.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 11.6.1.4.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 11.6.1.4.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 11.6.1.4.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 11.6.1.5.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 11.6.1.5.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 11.6.1.5.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 11.6.1.6.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 11.6.1.6.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 11.6.1.6.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)

12. Latin America Dura Substitute Market, 2023-2033, USD (Million)

  • 12.1. Market Overview
  • 12.2. Dura Substitute Market: By , 2023-2033, USD (Million)
  • 12.3. Dura Substitute Market: By Material, 2023-2033, USD (Million)
  • 12.4. Dura Substitute Market: By Application, 2023-2033, USD (Million)
  • 12.5. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
  • 12.6.Dura Substitute Market: By Region, 2023-2033, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 12.6.1.1.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 12.6.1.1.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 12.6.1.1.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 12.6.1.2.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 12.6.1.2.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 12.6.1.2.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 12.6.1.3.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 12.6.1.3.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 12.6.1.3.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)

13. Middle East and Africa Dura Substitute Market, 2023-2033, USD (Million)

  • 13.1. Market Overview
  • 13.2. Dura Substitute Market: By , 2023-2033, USD (Million)
  • 13.3. Dura Substitute Market: By Material, 2023-2033, USD (Million)
  • 13.4. Dura Substitute Market: By Application, 2023-2033, USD (Million)
  • 13.5. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
  • 13.6.Dura Substitute Market: By Region, 2023-2033, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 13.6.1.1.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 13.6.1.1.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 13.6.1.1.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 13.6.1.2.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 13.6.1.2.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 13.6.1.2.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Dura Substitute Market: By , 2023-2033, USD (Million)
        • 13.6.1.3.2. Dura Substitute Market: By Material, 2023-2033, USD (Million)
        • 13.6.1.3.3. Dura Substitute Market: By Application, 2023-2033, USD (Million)
        • 13.6.1.3.4. Dura Substitute Market: By End-user, 2023-2033, USD (Million)

14. Company Profile

  • 14.1. Cook Medical LLC
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. B. Braun Melsungen AG
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Integra LifeSciences
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Cousin Surgery
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. W. L. Gore & Associates, Inc.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Biosynth Lifesciences
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Acera Surgical, Inc.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Medprin
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Medtronic
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Stryker
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. DePuy Synthes
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Gunze Limited
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. Baxter
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives
  • 14.14. Bennett Health, Inc.
    • 14.14.1. Company Overview
    • 14.14.2. Financial Performance
    • 14.14.3. Product Portfolio
    • 14.14.4. Strategic Initiatives
  • 14.15. RTI Surgical
    • 14.15.1. Company Overview
    • 14.15.2. Financial Performance
    • 14.15.3. Product Portfolio
    • 14.15.4. Strategic Initiatives
  • 14.16. Natus Medical Incorporated
    • 14.16.1. Company Overview
    • 14.16.2. Financial Performance
    • 14.16.3. Product Portfolio
    • 14.16.4. Strategic Initiatives
  • 14.17. Other prominent players
    • 14.17.1. Company Overview
    • 14.17.2. Financial Performance
    • 14.17.3. Product Portfolio
    • 14.17.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제